Higher concentrations (1-2%) are typically used in active hair restoration protocols
The global adoption of LCIG therapy, led to some reports of potential complications related to peripheral nerve toxicity and abnormal vitamin metabolism (Taher et al
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025
Compounded GHK-CU Peptide for skin health GHK-CU is a naturally occurring copper peptide known for its role in skin health, tissue repair, and cellular regeneration
When Will You See Results
Cook KL, Soto-Pantoja DR, Abu-Asab M, Clarke PA, Roberts DD, Clarke R